Millennium Management is a multi-strategy hedge fund that employs a decentralized platform model, utilizing numerous independent investment teams to pursue diverse strategies across various asset classes and geographies. Their investment focus includes quantitative analysis, convertible arbitrage, merger arbitrage, fundamental analysis, relative value fundamental equity, equity arbitrage, fixed income, and commodities, all while emphasizing rigorous risk management.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is growth (75% of deals). Average disclosed round size is $407.0M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$83.5B
Top Stage
Growth
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Carmot Therapeutics | Series E | $150M | May 2023 |
 Caris Life Sciences | Growth | $830M | May 2021 |
 Starling Bank | Growth | $272M | Mar 2021 |
| Starling Bank | Growth | $376M | — |
Top Co-Investors
Fidelity Investments2 shared
Qatar Investment Authority2 shared
Railpen2 shared
Deep Track Capital1 shared
Franklin Templeton1 shared
Frazier Life Sciences1 shared
Janus Henderson Investors1 shared
RA Capital Management1 shared
The Column Group1 shared
Willett Advisors1 shared
Sixth Street Growth1 shared
T. Rowe Price Associates, Inc.1 shared
Silver Lake1 shared
Coatue Management1 shared
Neuberger Berman1 shared
Highland Capital Partners1 shared
Rock Springs Capital1 shared
Last updated: 16 April 2026